GeneBio Systems
PGF2a ELISA kit (General species)
PGF2a ELISA kit (General species)
SKU:CEA749Ge
Couldn't load pickup availability
Size: 96Tests
# of Times Cited in literature: 12
Prepare Time: 1-3 days(please inquire for mutiple units)
Target Name: PGF2a
Target Full Name: Prostaglandin F2 Alpha
Alternative Names: PGF2A; PGF2-A; PG-F2a
Target Species: General species
Uniprot: -
Gene ID: -
Featured Series: CE kit
Featured Series Function: Detects small molecule
Specificity: Reactive with General species PGF2a / Prostaglandin F2 Alpha
Method: Colormetric
Detection principle: Competitive Inhibition
Detection range: 9.88-800pg/mL
Sensitivity: 4.13pg/mL
Assay Time: 2h
Sample Size: 50uL
Recommended/Predicted Sample Types: Serum, Plasma and other Biological Fluids
Assay Precision: Intra-Assay: CV<10%, Inter-Assay: CV<12%
Reproducibility test menthod: Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Prostaglandin F2 Alpha (PGF2a) were tested 20 times on one plate, respectively. Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Prostaglandin F2 Alpha (PGF2a) were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100
Storage: 4°C for 1 month/ -20°C for long-term(One year within shelf life)
Shelf-life: 12 months
Specificity: This assay has high sensitivity and excellent specificity for detection of Prostaglandin F2 Alpha (PGF2a). No significant cross-reactivity or interference between Prostaglandin F2 Alpha (PGF2a) and analogues was observed.
Stability: The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition. To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.
Assay procedure summary: 1. Prepare all reagents, samples and standards; 2. Add 50µL standard or sample to each well. And then add 50µL prepared Detection Reagent A immediately. Shake and mix. Incubate 1 hour at 37°C; 3. Aspirate and wash 3 times; 4. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C; 5. Aspirate and wash 5 times; 6. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C; 7. Add 50µL Stop Solution. Read at 450 nm immediately.
Test principle: This assay employs the competitive inhibition enzyme immunoassay technique. A monoclonal antibody specific to PGF2a has been pre-coated onto a microplate. A competitive inhibition reaction is launched between biotin labeled PGF2a analogues and unlabeled antigen (Standards or samples) with the pre-coated antibody. After incubation the unbound conjugate is washed off. Next, avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. The amount of bound HRP conjugate is reverse proportional to the concentration of PGF2a in the sample. After addition of the substrate solution, the intensity of color developed is reverse proportional to the concentration of PGF2a in the sample.
Research Area: Metabolic pathway;Cardiovascular biology;Hormone metabolism;
References Citing This Product: Vitex negundo?inhibits cyclooxygenase-2 inflammatory cytokine-mediated inflammation on carrageenan-induced rat hind paw edema
Effects of different ventilation strategies on exhaled nitric oxide in geriatric abdominal surgery
Application of atosiban in frozen-thawed cycle patients with different times of embryo transfers
Administration of atosiban in patients with endometriosis undergoing frozen–thawed embryo transfer: a prospective, randomized study
The anti-inflammatory and anti-oxidative effects of conbercept in treatment of macular edema secondary to retinal vein occlusion
Association of fasting glucagon-like peptide-1 with oxidative stress and subclinical atherosclerosis in type 2 diabetes
Supplementation with Korean Red Ginseng Improves Current Perception Threshold in Korean Type 2 Diabetes Patients: A Randomized, Double-Blind, Placebo …
Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress
The microvesicle/CD36 complex triggers a prothrombotic phenotype in patients with non‐valvular atrial fibrillation
The effect of Korean Red Ginseng on sarcopenia biomarkers in type 2 diabetes patients
